Pinover W - Search Results

1

Prostate cancer risk assessment program. A model for the early detection of prostate cancer.

Bruner DW, Baffoe-Bonnie A, Miller S, Diefenbach M, Tricoli JV, Daly M, Pinover W, Grumet SC, Stofey J, Ross E, Raysor S, Balshem A, Malick J, Engstrom P, Hanks GE, Mirchandani I. Bruner DW, et al. Among authors: pinover w. Oncology (Williston Park). 1999 Mar;13(3):325-34; discussion 337-9, 343-4 pas. Oncology (Williston Park). 1999. PMID: 10204154

2

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.

Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D. Uzzo RG, et al. Among authors: pinover wh. Urology. 2003 Apr;61(4):754-9. doi: 10.1016/s0090-4295(02)02524-4. Urology. 2003. PMID: 12670560

3

Is there an increased risk of second primaries following prostate irradiation?

Movsas B, Hanlon AL, Pinover W, Hanks GE. Movsas B, et al. Among authors: pinover w. Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):251-5. doi: 10.1016/s0360-3016(97)00570-1. Int J Radiat Oncol Biol Phys. 1998. PMID: 9607337

4

Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer.

Tricoli JV, Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE. Tricoli JV, et al. Among authors: pinover wh. Urology. 1999 Jul;54(1):178-82. doi: 10.1016/s0090-4295(99)00129-6. Urology. 1999. PMID: 10414748

5

Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer.

Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE, Tricoli JV. Winter DL, et al. Among authors: pinover wh. Urology. 2001 Oct;58(4):614-8. doi: 10.1016/s0090-4295(01)01273-0. Urology. 2001. PMID: 11597555 Clinical Trial.

6

Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis.

Pinover WH, Hanlon A, Lee WR, Kaplan EJ, Hanks GE. Pinover WH, et al. Cancer. 1996 Apr 1;77(7):1334-41. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1334::AID-CNCR17>3.0.CO;2-2. Cancer. 1996. PMID: 8608512 Clinical Trial.

7

Conformal external beam treatment of prostate cancer.

Hanks GE, Hanlon AL, Schultheiss TE, Freedman GM, Hunt M, Pinover WH, Movsas B. Hanks GE, et al. Among authors: pinover wh. Urology. 1997 Jul;50(1):87-92. doi: 10.1016/s0090-4295(97)00226-4. Urology. 1997. PMID: 9218024

8

The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy.

Horwitz EM, Hanlon AL, Pinover WH, Hanks GE. Horwitz EM, et al. Among authors: pinover wh. Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):519-23. doi: 10.1016/s0360-3016(98)00095-9. Int J Radiat Oncol Biol Phys. 1998. PMID: 9635697

9

Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy.

Iyer RV, Hanlon AL, Pinover WH, Hanks GE. Iyer RV, et al. Among authors: pinover wh. Cancer. 1999 Apr 15;85(8):1816-21. doi: 10.1002/(sici)1097-0142(19990415)85:8<1816::aid-cncr23>3.0.co;2-u. Cancer. 1999. PMID: 10223577

10

Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy.

Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Schultheiss TE. Hanks GE, et al. Among authors: pinover wh. Cancer J Sci Am. 1999 May-Jun;5(3):152-8. Cancer J Sci Am. 1999. PMID: 10367171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters